Copertina

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Jacqueline Chua, Chi Li, Florina Antochi, Eduard Toma, Damon Wong, Bingyao Tan, Gerhard Garhöfer, Saima Hilal, Alina Popa‐Cherecheanu, Christopher Li‐Hsian Chen, Leopold Schmetterer
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
di: Zheng Long Lee, et al.
Pubblicazione: (2026)

Association of arterial structure and function with incident cardiovascular diseases and cognitive decline
di: Caroline Robert, et al.
Pubblicazione: (2025)

Risk prediction of mild cognitive impairment using electronic health record data
di: Gang Li, et al.
Pubblicazione: (2025)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
di: Julius Opwonya, et al.
Pubblicazione: (2024)

Prevalence and predictors of diagnosed mild cognitive impairment among Medicare beneficiaries
di: Elyse Couch, et al.
Pubblicazione: (2025)

The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
di: Simone Salemme, et al.
Pubblicazione: (2025)

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
di: Sebastiaan De Keersmaecker, et al.
Pubblicazione: (2024)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
di: Adam H. Dyer, et al.
Pubblicazione: (2025)

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease
di: Kevin Duff, et al.
Pubblicazione: (2024)

Correction to “The prognosis of mild cognitive impairment: A systematic review and meta‐analysis”
Pubblicazione: (2025)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
di: Marieclaire Overton, et al.
Pubblicazione: (2025)

The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
di: Craig Ritchie, et al.
Pubblicazione: (2025)

Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort
di: Joyce R. Chong, et al.
Pubblicazione: (2024)

Reversal of the concreteness effect can be detected in the natural speech of older adults with amnestic, but not non‐amnestic, mild cognitive impairment
di: Luwen Cao, et al.
Pubblicazione: (2024)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
di: Sunu Mathew, et al.
Pubblicazione: (2025)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
di: Rachel R. Jin, et al.
Pubblicazione: (2025)

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance
di: Kay Jann, et al.
Pubblicazione: (2025)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
di: Yuhan Xie, et al.
Pubblicazione: (2025)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
di: Gustavo Luis Verón, et al.
Pubblicazione: (2025)

Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
di: Jessie T. Yan, et al.
Pubblicazione: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
di: María A. Rodríguez‐Santiago, et al.
Pubblicazione: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
di: Juliana N. Souza‐Talarico, et al.
Pubblicazione: (2025)

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies
di: Paul C. Donaghy, et al.
Pubblicazione: (2026)

The classification of mild cognitive impairment or healthy ageing improves when including practice effects derived from a semantic verbal fluency task
di: Felix Dörr, et al.
Pubblicazione: (2025)

Optical coherence tomography as a potential biomarker for the logopenic variant of primary progressive aphasia: A cross‐sectional prospective study
di: Fei Wu, et al.
Pubblicazione: (2025)

Sex‐ and age‐specific effect of known type 2 diabetes mellitus on incident mild cognitive impairment five years later: Results from the population‐based Heinz Nixdorf Recall study
di: Anna Lena Platzbecker, et al.
Pubblicazione: (2025)

APOE ε4 allele status modulates the spatial patterns of progressive atrophy in the temporal lobes after mild traumatic brain injury
di: Shuoqiu Gan, et al.
Pubblicazione: (2024)

Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss
di: Vicente Medel, et al.
Pubblicazione: (2024)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
di: Russell Banks, et al.
Pubblicazione: (2024)

Modeling contributions of cognition and apathy to functional impairment in younger‐onset dementia
di: Samuel L. Warren, et al.
Pubblicazione: (2026)

Artificial intelligence detection of cognitive impairment in older adults during walking
di: Shuichi P. Obuchi, et al.
Pubblicazione: (2024)

Disentangling the effects of sex and gender on APOE ɛ4–related neurocognitive impairment
di: Tatiana Dessy, et al.
Pubblicazione: (2025)

Impact of dual sensory impairment on dementia: A systematic review and meta‐analysis
di: Daniele Urso, et al.
Pubblicazione: (2026)

Dementia stigma in the United States: variation by target gender, degree of impairment, and respondent characteristics
di: Lucas J. Hamilton, et al.
Pubblicazione: (2026)

Mild behavioral impairment in the general population aged 55+ and its association with incident dementia
di: Patricia Gracia‐García, et al.
Pubblicazione: (2024)

Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
di: Hankyung Jun, et al.
Pubblicazione: (2026)

Feasibility of assessing cognitive impairment via distributed camera network and privacy‐preserving edge computing
di: Chaitra Hegde, et al.
Pubblicazione: (2025)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
di: Miguel Ángel Rivas‐Fernández, et al.
Pubblicazione: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
di: Ihab Hajjar, et al.
Pubblicazione: (2024)

Midlife sensory and motor functions improve long‐term predictions of cognitive decline and incidence of cognitive impairment
di: Carla R. Schubert, et al.
Pubblicazione: (2024)